蔚來(09866.HK)低開近4% 六個月內第二度配股籌近79億港元
蔚來(09866.HK)六個月內第二度配股,隔晚(10日)美股ADR收跌8.9%至5.72美元,今日(11日)港股股價低開3.64%,報45.02元,市前成交16.34萬股,涉資735.58萬元。
蔚來擬配售最多約1.818億股A類普通股,每股美國存托股公開發行價5.57美元;每股A類普通股發行價43.36港元,較本港上日收市價折讓約7.2%。集資額料約78.8億港元。
蔚來稱,目前計劃將股權發行所得款項淨額用於投資智能電動汽車核心技術的研發、開發旗下品牌的未來技術平台及車型、擴大充換電網絡、進一步強化其資產負債表及用於一般企業用途。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.